Inc
Healthcare• British biotechnology0
Summit Therapeutics Inc
Market Cap
$17B
Stock Price
$19.46
SMMT
Corporate Profile
Summit Therapeutics Inc stands as a titan in the Healthcare sector. With a valuation of $17 Billion, the company employs over 130 people worldwide. Headquartered in British biotechnology, it continues to drive innovation and maintain its market dominance.
Financial Performance
Revenue
--
Market Cap
$17B
Stock
$19.46